BIO-TECHNE Corp (TECH)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $320k
- May 8 · Unusual
- Form 4 sales
- 164
- On record
- Form 144 notices
- 13
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 144 noticeNoticeAug 25, 2025 2025
Filed to sell 17,040 shares ($958k)
Baumgartner Robert V, Director
No 10b5-1 planFiling
- 2 Form 144 noticeNoticeAug 25, 2025 same day
Filed to sell 17,040 shares ($960k)
Nusse Roeland, Director
No 10b5-1 planFiling
- 3 Form 4 saleUnusualAug 25, 2025 same day
Sold 17,040 shares at $56.21 ($958k)
Baumgartner Robert V, Director
No 10b5-1 planSold 27.5% of holdings ($3.5M position)44,863 shares leftFollows a Form 144Filing
- 4 Form 4 saleUnusualAug 25, 2025 same day
Sold 17,040 shares at $56.36 ($960k)
Nusse Roeland, Director
No 10b5-1 planSold 27.7% of holdings ($3.5M position)44,559 shares leftFollows a Form 144Filing
- 5 Form 144 noticeNoticeFeb 17, 2026 +176 days
Filed to sell 1,976 shares ($117k)
Herr Amy E., Director
No 10b5-1 planFiling
- 6 Form 4 saleUnusualFeb 17, 2026 same day
Sold 1,976 shares at $59.11 ($117k)
Herr Amy E., Director
No 10b5-1 planSold 90.8% of holdings ($129k position)200 shares leftFollows a Form 144Filing
- 7 Form 144 noticeNoticeMay 8, 2026 +80 days
Filed to sell 6,636 shares ($320k)
Herr Amy E., Director
No 10b5-1 plan3.6x usual sizeFiling
- 8 Form 4 saleUnusualMay 8, 2026 same day
Sold 6,636 shares at $48.28 ($320k)
Herr Amy E., Director
No 10b5-1 planSold 97.1% of holdings ($330k position)200 shares left3.6x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales, notices and lockups (177)
Export watchlist as CSV| Source | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| May 8, 2026 | May 12, 2026 | Herr Amy E. | TECH | Director | Form 4 sale | 6,636 | $320k | 97.1% | Unusual | SEC |
| May 8, 2026 | May 8, 2026 | Herr Amy E. | TECH | Director | Form 144 notice | 6,636 | $320k | Notice | SEC | |
| Feb 17, 2026 | Feb 19, 2026 | Herr Amy E. | TECH | Director | Form 4 sale | 1,976 | $117k | 90.8% | Unusual | SEC |
| Feb 17, 2026 | Feb 17, 2026 | Herr Amy E. | TECH | Director | Form 144 notice | 1,976 | $117k | Notice | SEC | |
| Aug 25, 2025 | Aug 27, 2025 | Nusse Roeland | TECH | Director | Form 4 sale | 17,040 | $960k | 27.7% | Unusual | SEC |
| Aug 25, 2025 | Aug 27, 2025 | Baumgartner Robert V | TECH | Director | Form 4 sale | 17,040 | $958k | 27.5% | Unusual | SEC |
| Aug 25, 2025 | Aug 25, 2025 | Nusse Roeland | TECH | Director | Form 144 notice | 17,040 | $960k | Notice | SEC | |
| Aug 25, 2025 | Aug 25, 2025 | Baumgartner Robert V | TECH | Director | Form 144 notice | 17,040 | $958k | Notice | SEC | |
| Jun 9, 2025 | Jun 11, 2025 | Herr Amy E. | TECH | Director | Form 4 sale | 1,280 | $64k | 39.3% | Unusual | SEC |
| Jun 9, 2025 | Jun 9, 2025 | Herr Amy E. | TECH | Officer | Form 144 notice | 1,280 | $64k | Notice | SEC | |
| Feb 14, 2025 | Feb 18, 2025 | Herr Amy E. | TECH | Director | Form 4 sale | 1,860 | $123k | 48.5% | Unusual | SEC |
| Feb 14, 2025 | Feb 14, 2025 | Herr Amy E. | TECH | Domestic Partner of Director | Form 144 notice | 1,860 | $123k | Notice | SEC | |
| Jan 27, 2025 | Jan 29, 2025 | Kelderman Kim | TECH | Chief Executive Officer | Form 4 sale | 13,392 | $1M | 25.6% | Unusual | SEC |
| Jan 27, 2025 | Jan 27, 2025 | Kelderman Kim | TECH | Director, Officer | Form 144 notice | 13,392 | $1M | Notice | SEC | |
| Aug 8, 2024 | Aug 12, 2024 | Baumgartner Robert V | TECH | Director | Form 4 sale | 16,000 | $1.2M | 26.9% | Unusual | SEC |
| Aug 8, 2024 | Aug 8, 2024 | Baumgartner Robert V | TECH | Director | Form 144 notice | 16,000 | $1.2M | Notice | SEC | |
| May 14, 2024 | May 16, 2024 | Higgins John L | TECH | Director | Form 4 sale | 4,000 | $335k | 9.9% | No plan | SEC |
| May 14, 2024 | May 14, 2024 | Higgins John L | TECH | Director | Form 144 notice | 4,000 | $335k | Notice | SEC | |
| Mar 7, 2024 | Mar 11, 2024 | Nusse Roeland | TECH | Director | Form 4 sale | 10,400 | $801k | 19.4% | No plan | SEC |
| Mar 7, 2024 | Mar 7, 2024 | Nusse Roeland | TECH | Director | Form 144 notice | 10,400 | $801k | Notice | SEC | |
| Aug 30, 2023 | Sep 1, 2023 | Nusse Roeland | TECH | Director | Form 4 sale | 8,939 | $718k | 14.7% | No plan | SEC |
| Aug 30, 2023 | Aug 30, 2023 | Nusse Roeland | TECH | Director | Form 144 notice | 8,939 | $718k | Notice | SEC | |
| Jul 21, 2023 | Jul 25, 2023 | Kummeth Charles R. | TECH | Chief Executive Officer | Form 4 sale | 80,000 | $7.1M | 6.0% | Routine | SEC |
| Jul 21, 2023 | Jul 21, 2023 | Kummeth Charles R. | TECH | Officer | Form 144 notice | 80,000 | $7.1M | Notice | SEC | |
| Jun 7, 2023 | Jun 9, 2023 | Kummeth Charles R. | TECH | Chief Executive Officer | Form 4 sale | 322 | $27k | 0.0% | No plan | SEC |
| Jun 6, 2023 | Jun 6, 2023 | Kummeth Charles R. | TECH | Officer | Form 144 notice | 50,000 | $4.2M | Notice | SEC | |
| Dec 8, 2022 | Dec 9, 2022 | Furlow Brenda S. | TECH | SVP - GENERAL COUNSEL | Form 4 sale | 8,250 | $677k | 24.0% | Plan not stated | SEC |
| Aug 11, 2022 | Aug 12, 2022 | Higgins John L | TECH | Director | Form 4 sale | 2,504 | $949k | 31.3% | Unusual | SEC |
| Jun 8, 2022 | Jun 9, 2022 | Higgins John L | TECH | Director | Form 4 sale | 1,600 | $584k | 25.8% | Unusual | SEC |
| Jun 7, 2022 | Jun 9, 2022 | Kummeth Charles R. | TECH | CHIEF EXECUTIVE OFFICER | Form 4 sale | 5,104 | $1.9M | 2.5% | Plan not stated | SEC |
| Nov 19, 2021 | Nov 23, 2021 | Kelderman Kim | TECH | Pres. Diagnostics & Genom | Form 4 sale | 500 | $253k | 100.0% | Unusual | SEC |
| Nov 12, 2021 | Nov 16, 2021 | Eansor Norman David | TECH | President-Protein Sciences | Form 4 sale | 27,159 | $13.7M | 95.4% | Unusual | SEC |
| Nov 2, 2021 | Nov 3, 2021 | Hippel James | TECH | Chief Financial Officer | Form 4 sale | 9,022 | $4.7M | 45.6% | Unusual | SEC |
| Oct 29, 2021 | Nov 1, 2021 | Hippel James | TECH | Chief Financial Officer | Form 4 sale | 762 | $400k | 6.6% | Plan not stated | SEC |
| Sep 22, 2021 | Sep 24, 2021 | Kelderman Kim | TECH | Pres. Diagnostics & Genom | Form 4 sale | 822 | $435k | 100.0% | Unusual | SEC |
| Sep 7, 2021 | Sep 9, 2021 | Steer Randolph C | TECH | Director | Form 4 sale | 8,000 | $4.1M | 61.0% | Unusual | SEC |
| Sep 2, 2021 | Sep 7, 2021 | Hippel James | TECH | Chief Financial Officer | Form 4 sale | 10,000 | $5.1M | 48.0% | Unusual | SEC |
| Sep 2, 2021 | Sep 7, 2021 | Furlow Brenda S. | TECH | SVP - General Counsel | Form 4 sale | 6,871 | $3.5M | 47.4% | Unusual | SEC |
| Aug 31, 2021 | Sep 2, 2021 | Eansor Norman David | TECH | President-Protein Sciences | Form 4 sale | 1,538 | $774k | 53.9% | Unusual | SEC |
| Aug 31, 2021 | Sep 2, 2021 | Furlow Brenda S. | TECH | SVP - General Counsel | Form 4 sale | 5,000 | $2.5M | 39.6% | Unusual | SEC |
| Aug 23, 2021 | Aug 25, 2021 | Nusse Roeland | TECH | Director | Form 4 sale | 4,000 | $1.9M | 37.2% | Unusual | SEC |
| Aug 23, 2021 | Aug 25, 2021 | Baumgartner Robert V | TECH | Director | Form 4 sale | 4,000 | $1.9M | 29.4% | Unusual | SEC |
| Aug 19, 2021 | Aug 23, 2021 | Furlow Brenda S. | TECH | SVP - General Counsel | Form 4 sale | 3,538 | $1.7M | 31.7% | Unusual | SEC |
| Aug 9, 2021 | Aug 10, 2021 | Hippel James | TECH | Chief Financial Officer | Form 4 sale | 10,000 | $4.8M | 48.0% | Unusual | SEC |
| Jul 12, 2021 | Jul 14, 2021 | Hippel James | TECH | Chief Financial Officer | Form 4 sale | 10,000 | $4.6M | 52.3% | Unusual | SEC |
| Jun 18, 2021 | Jun 21, 2021 | Kummeth Charles R. | TECH | Chief Executive Officer | Form 4 sale | 12,498 | $5.6M | 7.5% | Plan not stated | SEC |
| Jun 14, 2021 | Jun 16, 2021 | Kummeth Charles R. | TECH | Chief Executive Officer | Form 4 sale | 7,481 | $3.4M | 4.3% | Plan not stated | SEC |
| Jun 9, 2021 | Jun 11, 2021 | Kelderman Kim | TECH | Pres. Diagnostics & Genom | Form 4 sale | 811 | $351k | 100.0% | Unusual | SEC |
| Jun 7, 2021 | Jun 9, 2021 | Hippel James | TECH | Chief Financial Officer | Form 4 sale | 9,942 | $4.2M | 52.1% | Unusual | SEC |
| May 25, 2021 | May 27, 2021 | Kelderman Kim | TECH | Pres. Diagnostics & Genom | Form 4 sale | 845 | $358k | 51.0% | Unusual | SEC |